| Literature DB >> 35097078 |
Hui-Da Zheng1, Jian-Hua Xu1, Yu-Rong Liu1, Ya-Feng Sun2.
Abstract
BACKGROUND: Currently, the standard surgical procedure for right colon cancer is complete mesocolic excision. Whether preventive extended lymph node dissection for colon cancer located in the hepatic flexure or right transverse colon should be performed remains controversial because the safety and effectiveness of the operation have not been proven, and infrapyloric lymph nodes (No. 206) and lymph nodes in the greater curvature of the stomach (No. 204) have not been strictly defined and distinguished as surgical indicators in previous studies. AIM: To analyze the metastatic status of infrapyloric lymph nodes and lymph nodes of the greater curvature of the stomach and perioperative complications and systematically evaluate the feasibility and safety of laparoscopic extended right colectomy using prospective data collected retrospectively.Entities:
Keywords: Gastroepiploic lymph nodes; Gastroparesis; Greater curvature of stomach lymph nodes; Infrapyloric lymph nodes; Laparoscopic extended right colectomy
Year: 2022 PMID: 35097078 PMCID: PMC8771377 DOI: 10.12998/wjcc.v10.i2.528
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1Surgery process photos. A: Five-hole method and main operation hole (black arrow); B: Caudal ventral approach in which the assistant lifts the ileocolonic vascular pedicle, and an ultrasonic knife is inserted obliquely in the direction of the superior mesenteric vein (SMV) (dotted line) into the small intestine ascending colon space; C: SMV with broken branches and Henle trunk (white arrow); D: Dissection of gastrocolic ligament lymph nodes; (E) Postoperative specimens.
Patient demographics and pathological characteristics
|
|
|
| Age, median (range) | 63.5 (26–75) |
| Sex (male) | 15 (75) |
| BMI (> 25) | 7 (35) |
| ASA ≤ 2 | 19 (95) |
| Tumor location | |
| Hepatic flexure | 13 (65) |
| Right transverse | 7 (35) |
| Pathology | |
| pT1 | 0 (0) |
| pT2 | 1 (5) |
| pT3 | 16 (80) |
| pT4 | 3 (15) |
| pN0 | 9 (45) |
| pN1 | 7 (35) |
| pN2 | 4 (20) |
| Perineural invasion | 5 (25) |
| Vascular invasion | 8 (40) |
| Defective mismatch repair | 5 (25) |
| Intraoperative complications | 0 (0) |
| Transition to open abdomen | 0 (0) |
CEA: Carcinoembryonic antigen; ASA: American Society of Anesthesiologists.
Peri- and postoperative patient outcomes
|
|
|
| Postoperative complication | 5 (25) |
| Anastomotic leakage | 0 (0) |
| Pancreatic fistula POPF grade | |
| Grade A | 0 (0) |
| Grade B | 1 (5) |
| Grade C | 0 (0) |
| Intestinal obstruction | 2 (10) |
| Chylous ascites | 1 (5) |
| Incision infection | 1 (5) |
| Gastroparesis | 2 (10) |
| Organ infection | 0 (0) |
| Gastrointestinal bleeding | 1 (5) |
| Clavien–Dindo classification | |
| Grade I | 1 (5) |
| Grade II | 5 (25) |
| Grade III and above | 1 (5) |
| Anal exhaust time, median (range) (d) | 3 (2-6) |
| Semiliquid diet, median (range) (d) | 5 (4-7) |
| Length of hospital stay | 11.5 (8-24) |
POPF: Postoperative pancreatic fistula.
Lymph node yield and metastases
|
|
|
| Total LN yield, mean ± SD | 39.3 ± 10.9 |
| LN metastases, median (range) | 1 (0-28) |
| No. 204 LN yield, median (range) | 2 (0-8) |
| No. 206 LN yield, median (range) | 2.5 (0-9) |
| Apical LN metastases | 8 (40) |
| No. 204 LN metastases | 1 (5) |
| No. 206 LN metastases | 1 (5) |
LN: Lymph node.
Characteristics of the patients with gastrocolic ligament lymph node metastasis
|
|
|
|
| Age (yr) | 69 | 61 |
| Gender | Female | Female |
| BMI | 30.04 | 20.96 |
| Symptom | Abdominal pain | Abdominal pain |
| CEA (ng/mL) | 33.28 | 25.39 |
| ASA score | II | III |
| Location | R | H |
| Pathological type | Ulcerative | Ulcerative |
| Differentiation | M | m-p |
| T stage | T4a | T3 |
| N stage | N2 | N2 |
| Tumor size (cm) | 6.0 × 3.5 | 6.0 × 5.5 |
| Mesocolic LN metastases/mesocolic LN yield ( | 5/34 | 28/58 |
| Apical LN metastases/apical LN yield ( | 4/13 | 16/30 |
| No. 204 LN metastases/GCLN yield ( | 1/2 | 0/2 |
| No. 206 LN metastases/GCLN yield ( | 0/6 | 3/3 |
| Venous invasion ( | Yes | Yes |
| Perineural invasion ( | No | Yes |
| Mismatch repair protein | Expression | Expression |
| Postoperative complications | No | No |
| Chemotherapy method | XELOX | XELOX |
| Relapse | No | Metastasis |
| Mortality | Alive | Death |
CEA: Carcinoembryonic antigen; ASA: American Society of Anesthesiologists; CEA: Carcinoembryonic antigen; ASA: American Society of Anesthesiologists; GCLN: Gastrocolic ligament lymph node; R: Right transverse; T: Hepatic flexure; m-p: moderately differentiated-poorly differentiated; XELOX: Oxaliplatin combined with capecitabine.